Pharmaceuticals

Global Fascioliasis Market Is Estimated To Witness High Growth

Larry Paige

Global Fascioliasis Market Is Estimated To Witness High Growth

The global Fascioliasis market is estimated to be valued at US$ 361.3 million in 2023 and is expected to exhibit a CAGR of 4.52% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Fascioliasis, also known as liver fluke infection, is a parasitic disease caused by liver flukes, primarily Fasciola hepatica and Fasciola gigantica. These parasites mainly infect the liver and can result in significant damage to the organ. The main treatment for fascioliasis includes the use of anthelmintic drugs such as triclabendazole and nitazoxanide. These drugs help in killing the parasites and eliminating the infection.

The need for effective treatment options for fascioliasis is increasing due to the high prevalence of liver fluke infections globally. The disease is commonly found in regions with agricultural practices involving the consumption of uncooked or undercooked freshwater plants contaminated with the parasites. The growing awareness regarding the diagnosis and treatment of fascioliasis is also contributing to market growth.

Market Key Trends:

One key trend in the global Fascioliasis market is the increasing research and development activities for the development of novel drugs and therapies. Pharmaceutical companies are focusing on developing more effective and targeted treatments to improve patient outcomes. For example, Novartis AG is actively involved in clinical trials for its drug candidate called Fasinex, which has shown promising results in treating fascioliasis.

PEST Analysis:

- Political: Governments play a crucial role in controlling and preventing the spread of fascioliasis through regulations and guidelines for agricultural practices.

- Economic: The economic burden of fascioliasis is significant, as the disease can lead to decreased productivity in the agriculture sector and increased healthcare costs.

- Social: The awareness and education programs conducted by healthcare organizations and government agencies help in creating awareness about the risks of fascioliasis and the importance of preventive measures.

- Technological: Advancements in diagnostic techniques such as serological tests and imaging modalities have improved the detection and diagnosis of fascioliasis.

Key Takeaways:

1: The global Fascioliasis market is expected to witness high growth, exhibiting a CAGR of 4.52% over the forecast period, due to increasing prevalence of liver fluke infections. The rise in cases of fascioliasis globally is driving the demand for effective treatment options.

2: Regionally, Asia Pacific is the fastest growing and dominating region in the Fascioliasis market due to the high prevalence of liver fluke infections in countries like China, Vietnam, and Indonesia. North America and Europe are also witnessing significant growth due to increasing awareness and improved healthcare infrastructure.

3: Key players operating in the global Fascioliasis market include Novartis AG, AMGIS Lifescience Ltd., Romark, AbbVie Inc., Merck KGaA, AdvaCare Pharma, Intas Pharmaceuticals Ltd., Procyon Life Sciences, Adroit Pharmachem Pvt Ltd., Sun Pharmaceutical Industries Ltd., RV Lifesciences Limited, Grampus Laboratories, and Janssen Pharmaceuticals, Inc. These companies are engaged in research and development activities to introduce innovative treatment options for fascioliasis.

In conclusion, the global Fascioliasis market is expected to witness significant growth due to the increasing prevalence of liver fluke infections. The development of novel drugs and therapies, along with government initiatives to control and prevent the spread of the disease, will further boost market growth. With ongoing research and advancements in diagnostic techniques, the market is expected to offer lucrative opportunities for key players in the coming years.

Larry Paige

Anthelmintics Is Fastest Growing Segment Fueling The Growth Of Fascioliasis Market

Leena Shedmake 2023-11-30

The global Fascioliasis Market is estimated to be valued at US$ 361. Anthelmintic drugs are essential in treating fascioliasis infection and helps control further spread of infection. 4 million people are estimated to be infected with fascioliasis globally which is fueling the sales of anthelmintic drugs developed for fascioliasis treatment. Key Takeaways The Global Fascioliasis Market Size was valued at US$ 361. Key players operating in the fascioliasis market are Novartis AG, AMGIS Lifescience Ltd.

Candidiasis Market Trends: Insights into Product Development and Adoption

Larry Paige 2023-07-05

The candidiasis market is witnessing notable trends in product development and adoption, driven by the evolving needs of healthcare providers and patients. These trends provide insights into the direction of the market and offer opportunities for stakeholders. This includes the exploration of new classes of antifungal drugs, combination therapies, and drug delivery systems. This trend highlights the importance of precise diagnostics and the potential for targeted therapies in the candidiasis market. Healthcare providers and pharmaceutical companies are investing in initiatives to raise awareness about candidiasis, its prevention, and appropriate management.

The Growing Pharmaceutical Water Market is driven by Stringent Regulatory Standards

Sneha 2024-03-07

The pharmaceutical water market involves the use of highly purified water in various pharmaceutical applications such as sterile manufacturing, oral and injectables manufacturing. The global pharmaceutical water market size is estimated to be valued at US$ 7. Key TakeawaysKey players operating in the pharmaceutical water market are Heidelberg Printing Machinery AG, Komori Corporation, Koenig & Bauer AG, Manroland Goss web systems, HP Inc. In terms of value, North America holds the major share of the pharmaceutical water market currently owing to stringent regulatory norms and established healthcare infrastructure. Get more insights on Pharmaceutical Water Market

Regional Analysis of the Biopharma Buffer Market: North America, Europe, Asia Pacific, and Rest of the World

Ben Wood 2023-07-06

The biopharma buffer market can be analyzed based on regional segmentation, including North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America holds a significant share in the Biopharma Buffer Market, primarily driven by the presence of established biopharmaceutical companies, advanced healthcare infrastructure, and favorable regulatory frameworks. Europe is another prominent region in the biopharma buffer market, with countries such as Germany, Switzerland, and the United Kingdom leading the way. The presence of contract manufacturing organizations (CMOs) and the adoption of advanced technologies fuel the market's expansion in Asia Pacific. Analyzing the biopharma buffer market regionally helps identify market trends, regulatory differences, and market dynamics specific to each region.

India Pharmaceutical Packaging Market Is Estimated To Witness High Growth Owing To Increasing Demand for Safe Drug Packaging

Pooja salve 2023-08-25

The India Pharmaceutical Packaging Market is estimated to be valued at USD 1,573. A) Market Overview: The India Pharmaceutical Packaging Market refers to the packaging solutions specifically designed for pharmaceutical products. B) Market Key Trends: One key trend driving the growth of the India Pharmaceutical Packaging Market is the increasing demand for safe drug packaging. - The fastest growing and dominating region in the India Pharmaceutical Packaging Market is North India, which is home to several pharmaceutical manufacturing hubs and healthcare facilities. In conclusion, the India Pharmaceutical Packaging Market is experiencing significant growth due to the increasing demand for safe drug packaging.

Market Insights: Understanding the Dynamics of the Scopolamine Market

Steve martin 2023-06-20

This report provides in-depth market insights, offering a comprehensive understanding of the dynamics driving the Scopolamine market. The report delves into the demand-supply dynamics, market competition, and regulatory landscape governing the Scopolamine Market. Moreover, the report examines the market dynamics from a regional perspective, considering the market trends and opportunities across different geographic regions. By providing a thorough understanding of the market dynamics, this report equips stakeholders with actionable insights to make informed business decisions and capitalize on the opportunities presented by the Scopolamine market. These insights help stakeholders understand the market's growth potential and make informed decisions to capitalize on the evolving Scopolamine market.

WHO TO FOLLOW

MORE FROM AUTHOR

Global Microdermabrasion Devices Market Is Estimated To Witness High Growth

Larry Paige 2023-09-07

Global Methyl Myristate Market Is Estimated To Witness High Growth

Larry Paige 2023-09-07

Global Industrial Control Systems (ICS) Market Is Estimated To Witness High Growth

Larry Paige 2023-09-07

India Fluorinated Organic Compounds Market Is Estimated To Witness High Growth

Larry Paige 2023-09-07

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Global Viscosupplementation Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Osteoarthritis and Growing Demand for Minimally Invasive Treatment Options

savi jadhav 2023-08-29

The global Viscosupplementation Market is estimated to be valued at US$ 3,146. High Cost: Viscosupplementation treatment can be costly, limiting its accessibility to a certain segment of the population. Competition from Alternative Treatments: The viscosupplementation market faces competition from alternative treatments such as oral medications, physical therapy, and surgical interventions. Stringent Regulatory Approval Process: The viscosupplementation market is subject to regulatory scrutiny, and stringent approval processes can pose challenges for market players. D) Key Takeaways:1: The global viscosupplementation market is expected to witness high growth, exhibiting a CAGR of 8.

sachin sadgir 2023-05-11

They offer patients access to the benefits of Herceptin at a lower cost, which is expected to improve access to treatment for many patients. They offer patients access to the benefits of Herceptin at a lower cost, which is expected to improve access to treatment for many patients. Like Herceptin, a Herceptin Biosimilar targets the HER2 protein, preventing it from activating cell growth and division. The mechanism of action of a Herceptin biosimilar is the same as that of the reference product. The most significant benefit of a Herceptin biosimilar is its lower cost compared to the reference product. Another potential benefit of a Herceptin Biosimilar is the opportunity for innovation.

Contract Pharmaceutical Manufacturing Market: Strategies for Successful Partnerships

gauri kanale 2023-06-15

In the Contract Pharmaceutical Manufacturing Market, transparency and open communication are key elements of successful partnerships. By fostering a collaborative approach, they can align their manufacturing capabilities and resources to meet the unique needs of pharmaceutical companies. This agility allows pharmaceutical companies to respond to market demands quickly and effectively. They demonstrate their commitment to quality, compliance, and continuous improvement through certifications, audits, and performance metrics. html

As A Pain Reliever, Lidocaine Ointment Can Reduce The Intensity Of Pain

Vaishnavi Kashid 2023-05-08

When used for local anaesthetic or nerve blocks, Lidocaine Ointment usually starts functioning within a few minutes and lasts between 30 minutes and three hours. It is frequently used with a tiny quantity of adrenaline (epinephrine) to extend its local effects and reduce bleeding. When used as a local anaesthetic, lidocaine has an intermediate duration of effectiveness with a quick start of action. For spinal and epidural anaesthesias, longer-acting drugs like bupivacaine are occasionally preferred; nevertheless, Lidocaine Ointment offers the benefit of a quick beginning of action. Adrenaline practically doubles the length of anaesthesia by vasoconstricting arteries, which reduces bleeding and delays the resorption of Lidocaine Ointment.

The Global Pharmaceutical Excipients Market Growth Accelerated By Increased Demand For Modified Release Formulations

Mia Yates 2024-01-30

The pharmaceutical excipients are chemicals formulated to serve pharmaceutical aid purposes alongside the active pharmaceutical ingredients in drug compositions and formulations. The Global Pharmaceutical Excipients Market Size is estimated to be valued at US$ 12. Modified release formulations require specialized excipients that can help in modifying drug release as per requirement. Increased demand for modified release dosage forms from pharmaceutical companies has accelerated demand for specialized excipients that help in developing such formulations. This has emerged as a key trend in the pharmaceutical excipients market driving increased research and development of novel excipients suitable for modified release drug delivery.

India Active Pharmaceutical Ingredients Market Growth is Accelerated by Increasing Generic Drugs Manufacturing

Sumedha 2024-01-15

The active pharmaceutical ingredients (API) are the component of any drug that produces its effects. The rising prevalence of chronic diseases and growing geriatric population propel the demand for affordable drugs, boosting the active pharmaceutical ingredients market in India. This opportunity can propel the growth of the active pharmaceutical ingredients market in India over the forecast period. Porter's AnalysisThreat of new entrants: The threat of new entrants in the India active pharmaceutical ingredients market is moderate. Key TakeawaysThe India Active Pharmaceutical Ingredients Market Size is expected to witness high growth over the forecast period of 2023-2030 supported by a growing domestic pharmaceutical industry and rising exports.

India Pharmaceutical Packaging Market is Anticipated to Witness High Growth Owing to Increased Pharmaceutical Sector Growth

Ishika cmi 2024-03-21

The pharmaceutical industry in India has witnessed substantial growth in recent times and has emerged as the third-largest pharmaceutical market globally. The Indian pharmaceutical packaging market is estimated to be valued at US$ 1. Various opportunities exist in the India Pharmaceutical Packaging Market Size including growth in chronic disease treatment, development of biopharmaceuticals, growth of medical devices industry. Segment Analysis The India pharmaceutical packaging market can be segmented based on packaging type into primary packaging, secondary packaging, and tertiary packaging. Explore Our More Blogs on India Pharmaceutical Packaging Market

Non-Small Cell Lung Cancer Market Analysis, Market Share, Market Research Report, Leading Companies

Ankit Nigam 2020-10-23

According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.

The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.

Click here to know more on Non-Small Cell Lung Cancer pipeline NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many othersKey Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.Market DriverMarket Barrier The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.Detailed Non-Small Cell Lung Cancer market size by therapies, covering the United States, EU5 and Japan from 2017-2030.Reimbursement scenario and Key Opinion Leader Views Table of ContentsKey InsightsExecutive Summary of NSCLCSWOT Analysis of NSCLCNSCLC: Market Overview at a Glance4.1.

Total Market size of NSCLC in JapanALK-Mutation—Market Size21.1.

Report MethodologyDelveInsight CapabilitiesDisclaimerAbout DelveInsight Request a Webex Demo to get a walk-through of the report: https://www.delveinsight.com/sample-request/non-small-cell-lung-cancer-marketRelated Reports:Non-Small Cell Lung Cancer Epidemiology Forecast to 2030Non-Small Cell Lung Cancer Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020Non-Small Cell Lung Cancer Pipeline Insights, 2020About DelveInsightDelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment.

Pharmaceutical Excipients Market Covid19 Impact Analysis And Forecast 2019-2027

Rahul Kumar Yadav 2023-08-04

The Pharmaceutical Excipients Market, like many other industries, has experienced significant disruptions and changes due to the COVID-19 pandemic. This impacted the overall growth of the Pharmaceutical Excipients Market, as investments and research were redirected towards pandemic-related solutions. As the world gradually recovers from the pandemic, the Pharmaceutical Excipients Market is expected to rebound. The COVID-19 pandemic had a mixed impact on the Pharmaceutical Excipients Market. As the world learns from the lessons of the pandemic, the pharmaceutical excipients market will likely emerge stronger and more resilient in the face of future challenges.

U.S. Sucralfate Market to Grow with Rising Demand for Peptic Ulcer Treatment

Purvaja 2024-02-21

The U. The U. The sucralfate market witnesses high demand in the U. Social: As life expectancy increases, the aging population is more susceptible to gastrointestinal diseases requiring sucralfate treatment. The U. Factors such as high healthcare expenditure, growing pharmaceutical industry, and presence of key market players have supported market concentration in the U. The Asia Pacific region is projected to be the fastest growing market during the forecast period.

India Pharmaceutical Packaging Market is Estimated to Witness High Growth Owing to Opportunity of Growth in Healthcare Expenditure

Rajkumar cmi 2024-01-30

The global India Pharmaceutical Packaging Market is estimated to be valued at US$ 1. The growing healthcare expenditure will drive increased demand for pharmaceutical products stimulating growth of pharmaceutical packaging in India. Competitive rivalry: The India pharmaceutical packaging market sees high competition owing to presence of numerous regional and global players offering substitutable product ranges. Key Takeaways The India pharmaceutical packaging market is expected to witness high growth over the forecast period 2024 to 2031 supported by rising domestic pharmaceutical production and consumption. Key players operating in the India pharmaceutical packaging market are IBM Corporation, Lucid Work Incorporation, Microsoft Corporation, Dassault Systems S.

Precision Medicine: Bridging the Gap between Research and Clinical Practice

harries jackson 2023-06-16

However, precision medicine aims to overcome this gap by integrating cutting-edge research findings into routine clinical care. One way precision medicine bridges this gap is through the integration of genomics and molecular biology into clinical practice. Furthermore, Precision Medicine leverages technology and data analytics to translate research insights into actionable information for healthcare professionals. Moreover, precision medicine fosters collaboration between researchers, clinicians, and patients. By breaking down silos and encouraging collaboration, precision medicine accelerates the translation of research findings into clinical practice.

Epinephrine and Cardiac Arrest: Reviving Hearts in Critical Moments

Anjali Pawar 2023-05-22

It is important to note that while epinephrine is a powerful life-saving medication, it should be used with caution and under the guidance of trained healthcare professionals. Improper administration or excessive doses can lead to adverse effects, such as increased heart rate, hypertension, and cardiac arrhythmias. Furthermore, epinephrine is also employed in the field of anesthesiology. During anesthesia, patients may experience adverse reactions, such as severe drops in blood pressure or a life-threatening allergic response to medication. From anaphylaxis to cardiac arrest and anesthesia complications, this hormone and neurotransmitter plays a critical role in stabilizing patients and improving their chances of survival.

Unveiling Opportunities in the India & Oman Pharmaceutical Industry Market

Yashvi Gadhiya 2023-08-30

Porter's Analysis - Threat of new entrants: The pharmaceutical industry is highly regulated, making it difficult for new players to enter. - Bargaining power of suppliers: Pharmaceutical companies rely on raw materials and active pharmaceutical ingredients (APIs) sourced from suppliers. - Competitive rivalry: The India & Oman Pharmaceutical Industry Market is highly competitive, with key players such as Pfizer, Bristol Myers Squibb, Novartis, and Sanofi competing for market share. The India & Oman Pharmaceutical Industry Market Size is poised for significant growth, with a projected CAGR of 12. In conclusion, the India & Oman Pharmaceutical Industry Market offers tremendous growth prospects driven by the rising healthcare needs in these regions.

Global Viscosupplementation Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Osteoarthritis and Growing Demand for Minimally Invasive Treatment Options

savi jadhav 2023-08-29

Pharmaceutical Excipients Market Covid19 Impact Analysis And Forecast 2019-2027

Rahul Kumar Yadav 2023-08-04

sachin sadgir 2023-05-11

U.S. Sucralfate Market to Grow with Rising Demand for Peptic Ulcer Treatment

Purvaja 2024-02-21

Contract Pharmaceutical Manufacturing Market: Strategies for Successful Partnerships

gauri kanale 2023-06-15

India Pharmaceutical Packaging Market is Estimated to Witness High Growth Owing to Opportunity of Growth in Healthcare Expenditure

Rajkumar cmi 2024-01-30

As A Pain Reliever, Lidocaine Ointment Can Reduce The Intensity Of Pain